Language
繁體中文
簡體中文
English
關於安成About Us
Company Profile
Management Team
Milestones
Plant & Quality
Join Us
Contact
Products
研究與發展Research & Development
High Barrier Generics
投資人關係
Shareholder Services
Corporate Governance
Unaudited Monthly Sales
Financial Report
Shareholder Contacts
新聞發佈News & Media
News
Announcement
1
2
/ Press Releases
2022/06
TWi’ ANDA for Guanfacine HCl Tablets (equivalent to Tenex®) has been officially approved by US FDA
2022.04
TWi’ ANDA for Fluphenazine HCl Tablets (equivalent to Prolixin®) has been officially approved by US FDA
2022.03
TWi officially launches its Mycophenolic Acid Delayed-Release Tablets in TWi label
2022.01
TWi officially launches an Authorized Generic of Dexilant® (Dexlansoprazole) Delayed-Release Capsules from Takeda
2021-10
TWi’ ANDA for Metformin HCl Extended-Release Tablets (equivalent to Fortamet®) has been officially approved by US FDA